A case of sporadic Creutzfeldt-Jakob disease with both plaque and synaptic-type deposition of prion protein

Neuropathology

Volumn 20, Issue 1, 2000, Pages 49-55

  Tanaka, Shinichiro ^a,b   Ota, Makoto ^c   Ohama, Eisaku ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c Matsue Seikyo General Hospital   (Japan)

Author keywords

Creutzfeldt Jakob disease; Immunohistochemistry; Plaque type deposition; Prion protein; Synaptic type deposition

Indexed keywords

FORMIC ACID; PRION PROTEIN;

AGED; ARTICLE; AUTOCLAVE; CASE REPORT; CEREBELLUM; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DISEASE COURSE; DISEASE DURATION; ELECTROENCEPHALOGRAM; FEMALE; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; GRAY MATTER; HIPPOCAMPUS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOCLONUS; NEUROPATHOLOGY; PARKINSONISM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STAINING; SUBICULUM; SYMPTOM; VISUAL HALLUCINATION;

AGED; CREUTZFELDT-JAKOB SYNDROME; FATAL OUTCOME; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; PRIONS; SENILE PLAQUES; SYNAPSES;

EID: 0034030312     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.2000.00283.x     Document Type: Article

References (18)

1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136-144.
2. Budka H, Aguzzi A, Brown P et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995; 5: 459-466.
3. McLean CA, Ironside JW, Alpers MP et al. Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease: Evidence for strain of agent predominating over genotype of host. Brain Pathol 1998; 8: 429-437.
4. Kitamoto T, Tateishi J. Human prion diseases with variant prion protein. Philos Trans R Soc Lond B Biol Sci 1994; 343: 391-398.
5. Kitamoto T, Shin RW, Doh-ura K et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 1992; 140: 1285-94.
6. Miyazono M, Kitamoto T, Doh-ura K, Iwaki T, Tateishi J. Creutzfeldt-Jakob disease with codon 129 polymorphism (valine): A comparative study of patients with codon 102 point mutation or without mutations. Acta Neuropathol 1992; 84: 349-354.
7. MacDonald ST, Sutherland K, Ironside JW. A quantitative and qualitative analysis of prion protein immunohistochemical staining in Creutzfeldt-Jakob disease using four anti prion protein antibodies. Neurodegeneration 1996; 5: 87-94.
8. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 1987; 57: 230-236.
9. Bell JE, Gentleman SM, Ironside JW et al. Prion protein immunocytochemistry: UK five centre consensus report. Neuropathol Appl Neurobiol 1997; 23: 26-35.
10. Ironside JW. Human prion diseases. J Neural Transm Suppl 1996; 47: 231-246.
11. Kitamoto T, Doh-ura K, Muramoto T, Miyazono M, Tateishi J. The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system. Am J Pathol 1992; 141: 271-277.
12. Parchi P, Castellani R, Capellari S et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39: 767-778.
13. Doi-Yi R, Kitamoto T, Ogomori K, Mehraein P, Tateishi J. Distribution of prion protein in German patients with Creutzfeldt-Jakob disease is different from that in Japanese patients. Acta Neuropathol 1994; 87: 481-483.
14. Shimizu S, Hoshi K, Muramot T et al. Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch Neurol 1999; 56: 357-362.
15. Hainfellner JA, Liberski PP, Guiroy DC et al. Pathology and immunocytochemistry of a kuru brain. Brain Pathol 1997; 7: 547-553.
16. Hoque MZ, Kitamoto T, Furukawa H, Muramoto T, Tateishi J. Mutation in the prion protein gene at codon 232 in Japanese patients with Creutzfeldt-Jakob disease: A clinicopathological, immunohistochemical and transmission study. Acta Neuropathol (Berl) 1996; 92: 441-446.
17. Bell JE, Ironside JW. Neuropathology of spongiform encephalopathies in humans. Br Med Bull 1993; 49: 738-777.
18. Kretzschmar HA, Kitamoto T, Doerr-Schott J, Mehraein P, Tateishi J. Diffuse deposition of immunohistochemically labeled prion protein in the granular layer of the cerebellum in a patient with Creutzfeldt-Jakob disease. Acta Neuropathol 1991; 82: 536-540.